Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured some big numbers: 26 retractions for an engineer in Italy, all at once; 15 expressions of concern for Piero Anversa’s cardiac stem cell research; three retractions and 10 corrections for a researcher in South Korea; and also the retraction of a paper on ketamine for bipolar depression. Here’s what was happening elsewhere:

Like Retraction Watch? You can make a tax-deductible contribution to support our growth, follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up for an email every time there’s a new post (look for the “follow” button at the lower right part of your screen), or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

One thought on “Weekend reads: Meet journals’ research integrity czars; Duke set to settle big grant fraud case; what a cannabis stock’s collapse can teach investors”

  1. I, for one, welcome a journal of controversial ideas. I probably won’t bother reading it, because I am having enough trouble dealing with uncontroversial ideas. But for anyone genuinely worried about the impact such a journal will have, I believe the horse has bolted, been elected President and used Twitter to order an airstrike on the barn. The internet/world is full of trolls. Subjecting their work to peer review can’t possibly make things worse.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.